The TWH1500, using water-filtered infrared A with a high and most compliant energy input to deeper tissue layers (see wIRA insert hyperlink), is the first oncological local hyperthermia device that enables a contact-free supply of energy.

  • That allows for continous real-time thermographic control with automatic switch on and off control functions making possible a optimal and safe energy input, achieving an effective heating depth of (>40°C) of at least 15mm (>40°C) resp. 20mm (>39.5°C) if max. skin temperature is set at 42- 43°C.
  • Thereby, the incidents of thermal skin damage (TSD) ≥ grade 2 has been reduced to 0% (median in published microwave hyperthermia studies is approx. 25%). Additionally, the physiological reactions in the treatment area can be observed real-time and analyzed even afterwards.
  • The treatment is most agreeable for the patient. The patient does not suffer from any body fixation or painful applicator contact, e.g. with ulcerated lesions.

  • By a twin-applicator system, TWH1500 - independantly of heterogenous body contours - easily covers large treatment areas for effective hyperthermia of large-sized chest wall recurrence, especially in lymphangiosis carcinomatosa.

    Thermography-controlled wIRA superficial hyperthermia is an approved method in the "Quality assurance guidelines for superficial hyperthermia clinical trials", issued by ESHO (European Society for Hyperthermic Oncology) and published in Int J Hyperthermia. 2017 and Strahlenther Onkol 2017.